Literature DB >> 34379505

Pseudorabies Virus Inhibits Type I and Type III Interferon-Induced Signaling via Proteasomal Degradation of Janus Kinases.

Yue Yin1, Nicolás Romero1, Herman W Favoreel1.   

Abstract

Both type I and III interferons (IFNs) play a crucial role in host antiviral response by activating the JAK/STAT (Janus kinase/signal transducer and activator of transcription) signaling pathway to trigger the expression of antiviral IFN-stimulated genes (ISGs). We report that the porcine alphaherpesvirus pseudorabies virus (PRV) triggers proteasomal degradation of the key Janus kinases Jak1 and to a lesser extent Tyk2, thereby inhibiting both type I and III IFN-induced STAT1 phosphorylation and suppressing IFN-induced expression of ISGs. UV-inactivated PRV did not interfere with IFN signaling. In addition, deletion of the EP0 gene from the PRV genome or inhibition of viral genome replication did not affect PRV-induced inhibition of IFN signaling. To our knowledge, this is the first report describing Janus kinase degradation by alphaherpesviruses. These findings thus reveal a novel alphaherpesvirus evasion mechanism of type I and type III IFNs. IMPORTANCE Type I and III interferons (IFNs) trigger signaling via Janus kinases that phosphorylate and activate signal transducer and activator of transcription (STAT) transcription factors, leading to the expression of antiviral interferon-stimulated genes (ISGs) that result in an antiviral state of host cells. Viruses have evolved various mechanisms to evade this response. Our results indicate that an alphaherpesvirus, the porcine pseudorabies virus (PRV), inhibits both type I and III IFN signaling pathways by triggering proteasome-dependent degradation of the key Janus kinases Jak1 and Tyk2 and consequent inhibition of STAT1 phosphorylation and suppression of ISG expression. Moreover, we found that this inhibition is not caused by incoming virions and does not depend on expression of the viral EP0 protein or viral true late proteins. These data for the first time address alphaherpesvirus evasion of type III IFN-mediated signaling and reveal a previously uncharacterized alphaherpesvirus mechanism of IFN evasion via proteasomal degradation of Janus kinases.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34379505      PMCID: PMC8475505          DOI: 10.1128/JVI.00793-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Genomewide function conservation and phylogeny in the Herpesviridae.

Authors:  M M Albà; R Das; C A Orengo; P Kellam
Journal:  Genome Res       Date:  2001-01       Impact factor: 9.043

2.  Molecular characterization and antiviral analyses of porcine type III interferons.

Authors:  Yongming Sang; Raymond R R Rowland; Frank Blecha
Journal:  J Interferon Cytokine Res       Date:  2010-10-07       Impact factor: 2.607

3.  IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.

Authors:  Sergei V Kotenko; Grant Gallagher; Vitaliy V Baurin; Anita Lewis-Antes; Meiling Shen; Nital K Shah; Jerome A Langer; Faruk Sheikh; Harold Dickensheets; Raymond P Donnelly
Journal:  Nat Immunol       Date:  2002-12-16       Impact factor: 25.606

4.  Inhibition of the DNA-Sensing pathway by pseudorabies virus UL24 protein via degradation of interferon regulatory factor 7.

Authors:  Xuelan Liu; Mingliang Zhang; Chao Ye; Keyue Ruan; Aiyun Xu; Fei Gao; Guangzhi Tong; Hao Zheng
Journal:  Vet Microbiol       Date:  2021-02-27       Impact factor: 3.293

Review 5.  Shared and Distinct Functions of Type I and Type III Interferons.

Authors:  Helen M Lazear; John W Schoggins; Michael S Diamond
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

6.  Role for herpes simplex virus 1 ICP27 in the inhibition of type I interferon signaling.

Authors:  Karen E Johnson; Byeongwoon Song; David M Knipe
Journal:  Virology       Date:  2008-02-14       Impact factor: 3.616

7.  Herpes Simplex Virus 1 UL36USP Antagonizes Type I Interferon-Mediated Antiviral Innate Immunity.

Authors:  Hui Yuan; Jia You; Hongjuan You; Chunfu Zheng
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

8.  Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway.

Authors:  Shin-ichi Yokota; Noriko Yokosawa; Tamaki Okabayashi; Tatsuo Suzutani; Shunsuke Miura; Kowichi Jimbow; Nobuhiro Fujii
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Varicella Viruses Inhibit Interferon-Stimulated JAK-STAT Signaling through Multiple Mechanisms.

Authors:  Marieke C Verweij; Mary Wellish; Travis Whitmer; Daniel Malouli; Martin Lapel; Stipan Jonjić; Juergen G Haas; Victor R DeFilippis; Ravi Mahalingam; Klaus Früh
Journal:  PLoS Pathog       Date:  2015-05-14       Impact factor: 6.823

10.  Herpes simplex virus 1 targets IRF7 via ICP0 to limit type I IFN induction.

Authors:  David Shahnazaryan; Rana Khalil; Claire Wynne; Caroline A Jefferies; Joan Ní Gabhann-Dromgoole; Conor C Murphy
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

View more
  4 in total

Review 1.  Evasion of I Interferon-Mediated Innate Immunity by Pseudorabies Virus.

Authors:  Rui Zhang; Jun Tang
Journal:  Front Microbiol       Date:  2021-12-14       Impact factor: 5.640

2.  Alphaherpesvirus US3 protein-mediated inhibition of the m6A mRNA methyltransferase complex.

Authors:  Robert J J Jansens; Ruth Verhamme; Aashiq H Mirza; Anthony Olarerin-George; Cliff Van Waesberghe; Samie R Jaffrey; Herman W Favoreel
Journal:  Cell Rep       Date:  2022-07-19       Impact factor: 9.995

3.  Phospho-proteomics identifies a critical role of ATF2 in pseudorabies virus replication.

Authors:  Fang-Fang Jiang; Ren-Qi Wang; Chao-Yue Guo; Ke Zheng; Hai-Long Liu; Le Su; Sheng-Song Xie; Huan-Chun Chen; Zheng-Fei Liu
Journal:  Virol Sin       Date:  2022-06-07       Impact factor: 6.947

Review 4.  A Tug of War: Pseudorabies Virus and Host Antiviral Innate Immunity.

Authors:  Guangqiang Ye; Hongyang Liu; Qiongqiong Zhou; Xiaohong Liu; Li Huang; Changjiang Weng
Journal:  Viruses       Date:  2022-03-06       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.